New legislation introduced by a bipartisan group of US senators would make it more difficult for new and generic opioid drugs to obtain the approval of the US Food and Drug Administration (FDA). The ...
At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease. While this is good news for children in the U.S. born ...
It takes about 14 years to get a new drug approved by the Food and Drug Administration. That leaves drug companies about six years of exclusive sales until their 20-year patent expires, and they ...
FDA Commissioner Marty Makary defended himself in an interview with CNBC's David Faber. Makary has come under pressure for recent drug rejections. One of the most high-profile examples is the FDA's ...
At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease. While this is good news for children in the U.S. born ...